ACHE and early-onset autosomal dominant Alzheimer disease: Furthermore, ongoing research into novel AChE inhibitors, including synthetic compounds and natural extracts, continues to expand the therapeutic landscape for Alzheimer’s disease, with the aim of not only alleviating symptoms but also addressing the underlying pathophysiological mechanisms of the disease [14,15].